R1 RCM Inc.

R1 RCM Inc. is a leading provider of technology-driven solutions for healthcare revenue cycle management (RCM), aiming to transform the patient experience and financial performance of healthcare providers. The company's core business involves managing billing, claims processing, collections, and payments for hospitals, health systems, and physician groups. R1 RCM is headquartered in Chicago, Illinois.

Its offerings include end-to-end RCM services and a modular technology platform for in-house augmentation. R1 RCM's solutions cover the entire patient lifecycle, from pre-registration and financial clearance to charge capture, coding, billing, follow-up, and denials management. The company leverages automation, artificial intelligence (AI), and human expertise through its proprietary platforms, including "Phare: Healthcare's First Revenue Operating System" and R1 Entri. R1 RCM partners with a significant portion of top U.S. health systems and operates across the United States and India.

In November 2024, R1 RCM Inc. transitioned from a publicly traded company on Nasdaq to a privately held entity following its acquisition by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice in an $8.9 billion transaction. Joe Flanagan reassumed the role of Chief Executive Officer after the acquisition. The company continues to innovate, having launched the R37 AI innovation lab in partnership with Palantir to advance healthcare financial performance, and has recently introduced solutions like Scheduling Optimization and Phare OS expansion.